Search: onr:"swepub:oai:DiVA.org:uu-222605" >
The effect of the U...
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy : a collaborative meta-analysis
-
Dias, M M (author)
-
Pignon, J-P (author)
-
Karapetis, C S (author)
-
show more...
-
Boige, V (author)
-
- Glimelius, Bengt (author)
- Uppsala universitet,Enheten för onkologi
-
Kweekel, D M (author)
-
Lara, P N (author)
-
Laurent-Puig, P (author)
-
Martinez-Balibrea, E (author)
-
Páez, D (author)
-
Punt, C J A (author)
-
Redman, M W (author)
-
Toffoli, G (author)
-
- Wadelius, Mia (author)
- Uppsala universitet,Klinisk farmakogenomik och osteoporos,Clinical pharmacogenomics
-
McKinnon, R A (author)
-
Sorich, M J (author)
-
show less...
-
(creator_code:org_t)
- 2014-04-08
- 2014
- English.
-
In: The Pharmacogenomics Journal. - : Springer Science and Business Media LLC. - 1470-269X .- 1473-1150. ; 14:5, s. 424-431
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- To date, studies of irinotecan pharmacogenetics have mostly focused on the effect of the UGT1A1*28 allele on irinotecan-related toxicity. However, the clinical utility of routine UGT1A1*28 genotyping to pre-emptively adjust irinotecan dosage is dependent upon whether UGT1A1*28 also affects patient survival following irinotecan therapy. Previous observational studies evaluating the influence of UGT1A1*28 on survival have shown contradictory results. A systematic review and meta-analysis of both published and unpublished data were performed to summarize the available evidence of the relationship between the UGT1A1*28 allele and patient survival related to irinotecan therapy. Overall and progression-free survival meta-analysis data were available for 1524 patients and 1494 patients, respectively. The difference in the survival between patients of different UGT1A1*28 genotypes (homozygous, heterozygous or wild-type) who had received irinotecan was not found to be statistically significant. There was also no evidence of irinotecan dose, regimen or line of therapy having an impact on this association.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Dias, M M
-
Pignon, J-P
-
Karapetis, C S
-
Boige, V
-
Glimelius, Bengt
-
Kweekel, D M
-
show more...
-
Lara, P N
-
Laurent-Puig, P
-
Martinez-Balibre ...
-
Páez, D
-
Punt, C J A
-
Redman, M W
-
Toffoli, G
-
Wadelius, Mia
-
McKinnon, R A
-
Sorich, M J
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Clinical Laborat ...
- Articles in the publication
-
The Pharmacogeno ...
- By the university
-
Uppsala University